Cardiac Mapping Market Size, Share, Growth Analysis, By End user(Hospitals & Clinics, Diagnostic Centers, and Others), By Product(Contact Cardiac Mapping Systems, and Non-Contact Cardiac Mapping Systems), By Indication(Atrial Fibrillation, Atrial Flutter, AVNRT, And Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2783 | Region: Global | Published Date: July, 2024
Pages: 219 |Tables: 90 |Figures: 73

Cardiac Mapping Market Insights

Global Cardiac Mapping Market size was valued at USD 1.86 billion in 2022 and is poised to grow from USD 2.03 billion in 2023 to USD 4.01 billion by 2031, growing at a CAGR of 8.90% during the forecast period (2024-2031).

According to data released by the Heart Rhythm Society, approximately 14 million individuals in the United States are currently grappling with heart rhythm disorders. In response to this prevalent health concern, cardiac mapping systems have emerged as a non-invasive and sophisticated technique. This innovative approach involves the collection of electric impulses from the chest, with the obtained signals being seamlessly integrated with computed tomography (CT) scan data. The synergy of these elements results in the generation of high-quality cardiac maps. These intricate maps serve as invaluable tools for specialists in meticulously examining the intricate rhythm patterns of the heart.

By harnessing the capabilities of cardiac mapping, healthcare professionals can gain deeper insights into the complexities of heart rhythm disorders, paving the way for more informed diagnoses and tailored treatment strategies.

Market Snapshot - 2024-2031

Global Market Size

USD 1.86 billion

Largest Segment

Hospitals & Clinics

Fastest Growth

Hospitals & Clinics

Growth Rate

8.90% CAGR

Cardiac Mapping Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Cardiac Mapping Market Segmental Analysis

The cardiac mapping market segmentation, based on end user, includes Hospitals & Clinics, Diagnostic Centers and Others. The cardiac mapping market segmentation, based on product includes Contact Cardiac Mapping Systems, Non-Contact Cardiac Mapping Systems. The cardiac mapping market segmentation, based on indication, includes Atrial Fibrillation, Atrial Flutter, AVNRT And Others. By region, the study provides market insights into North America, Europe, Asia-Pacific and Rest of the World.

Analysis by End-Use

The diagnostic centers segment plays a crucial role in the cardiac mapping market as an integral component of the healthcare infrastructure focused on cardiovascular diagnostics. Diagnostic centers serve as specialized facilities equipped with advanced cardiac mapping technologies, providing a centralized hub for comprehensive cardiovascular assessments. These centers play a pivotal role in facilitating accurate and timely diagnosis of various cardiac arrhythmias and disorders.

The category of hospitals and clinics stands out as the primary revenue generator in the cardiac mapping market, given that these healthcare facilities serve as the focal points for the diagnosis and treatment of individuals with arrhythmias. The significance of hospitals and clinics in managing arrhythmias is underscored by the fact that a substantial portion of affected individuals seek medical attention and care in these settings. Additionally, the market is experiencing a noteworthy boost due to the continuous development of cardiac mapping technology.

Analysis by Product

The contact heart mapping segment has emerged as a key force in the market, mainly due to its ability to provide advanced 3D mapping and accurate detection and localization of ablation catheters of accurate diagnosis in the face of challenges. And it is the immediate driver needed if they intervene target wise. Notably, key players in the field are actively involved in special programs geared to address specific conditions such as ventricular tachycardia and supra-ventricular decompensation.

By 2022, the non-contact cardiac imaging system segment will emerge as a major contributor to the overall revenue of cardiac mapping market. Much attention has been paid to this section because of its unique utility in cardiac research. Unlike traditional mapping, noncontact mapping devices enable equipotential mapping of a single ectopic pulse equivalent to a clinical central arrhythmia, enabling reconstruction of its endocardial origin slowly.

Cardiac Mapping Market By Type

To get detailed analysis on other segments, Request For Free Sample Report

Cardiac Mapping Market Regional Insights

The North American cardiac mapping market is poised to assert its dominance, driven by several key factors. The region's leading position is attributed to the high prevalence of Cardiovascular Diseases (CVDs), a health concern that has prompted an increasing acceptance rate of cardiac mapping systems in the United States. The validation of these systems through clinical trials further contributes to the robust demand growth anticipated over the forecast period.

Anticipated to exhibit the fastest CAGR from 2024 to 2031, the Asia-Pacific Cardiac Mapping Market is poised for significant expansion. This growth trajectory is propelled by a substantial patient base grappling with cardiovascular disorders in the region, coupled with an escalating demand for enhanced solutions that can mitigate wait times and augment diagnostic effectiveness. Notably, China emerges as a key player in this dynamic market, holding the largest market share.

Cardiac Mapping Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Cardiac Mapping Market Dynamics

Drivers

Rising Number of Cardiovascular Diseases

  • The anticipated growth in market revenue for cardiac mapping systems is underpinned by two key factors: the rising likelihood of an increase in cardiovascular disorders and the continuous technological advancements in cardiac mapping diagnostics. According to the World Health Organisation (WHO), cardiovascular diseases (CVDs) stand as the leading cause of global mortality, responsible for approximately 17.9 million deaths annually. Notably, more than four out of every five CVD-related fatalities are attributed to heart attacks and strokes, with a significant proportion occurring in individuals under the age of 70.

Restraints

  • Increasing Trend in Complex Treatment of Cardiac Imaging

The cardiac mapping market faces a remarkable hurdle due to the prevailing tendency toward complex procedures associated with cardiac imaging; this trend has been identified as the major restraining factor affecting the revenue of the market so one of the. Difficulties with cardiac imaging protocols pose challenges, which may impede widespread adoption and availability. However, the integration of modern electrophysiological mapping systems, the use of sophisticated technologies in electrophysiological catheter manufacturing, and advances in cardiac imaging techniques have seen a good balance in the market. The use of A wide range of mapping strategies and techniques are possible during electrophysiological procedures.

Request Free Customization of this report to help us to meet your business objectives.

Cardiac Mapping Market Competitive Landscape

The competitive environment of the global Cardiac Mapping market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.

Top Player’s Company Profiles

  • Biosense Webster (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Medtronic (Ireland)
  • Abbott (U.S.)
  • BIOTRONIK (Germany)
  • MicroPort Scientific Corporation (China)
  • Acutus Medical Inc. (U.S.)
  • Catheter Precision (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • EP Solutions (Switzerland)
  • Lepu Medical Technology Co. Ltd. (China)
  • AngioDynamics (U.S.)
  • BioSig Technologies (U.S.)
  • APN Health (U.S.)
  • CoreMap (U.S.)
  • Kardium (Canada)
  • Epmap-System (Germany)

Recent Developments

  • In September 2022, Biosense Webster, a subsidiary of Johnson & Johnson Medtech, announced Octore, a topographic catheter designed to simplify the imaging of uncomplicated coronary heart disease A new eight-wire catheter stands out challenges electrophysiologists to accurately model conditions such as atrial fibrillation (AFib). To simplify the task The eighth, which holds promise, appears as a wonderful addition to the growing field of cardiac imaging technology, offering potential benefits for increased accuracy and efficiency in the diagnosis and treatment of simple heart failure.
  • In April 2022, a clinical trial aimed at determining the precise locations of NOAF delivery and rotors after cardiac surgery was initiated at the University Hospital of Basel, Switzerland Trial by computer so used a combination of low-dose tomography scan and non-invasive side mapping, including CardioInsightTM - 3D Mapping Prou ​​The doctor benefited Sponsored by the University Hospital, so this approach highlights the promise of advancing cardiac imaging techniques.

Cardiac Mapping Key Market Trends

  • During the forecast period, the cardiac imaging market is expected to witness substantial growth driven by multiple factors. Medical device companies are expected to play a key role in this trend as cutting-edge diagnostic technologies are increasingly adopted. Increasing demand for accurate cardiac testing has been identified as another major driver The growth is great because of its expansion.

Cardiac Mapping Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. The global cardiac mapping market is expected to grow significantly during the forecast period, driven by the expanding elderly population and prevalence and concomitant cardiovascular disease This population is expected to help increase the demand for advanced healthcare solutions including cardiac imaging systems. Furthermore, the market is poised to benefit from continuous technological advancements, which enhance the accuracy of cardiovascular disease diagnosis. The growing capabilities of cardiac imaging systems are likely to drive adoption in the coming years, consequently driving the overall growth of the global cardiac mapping market.

Report Metric Details
Market size value in 2023 USD 1.86 billion
Market size value in 2031 USD 4.01 billion
Growth Rate 8.90%
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • End user
    • Hospitals & Clinics, Diagnostic Centers, and Others
  • Product
    • Contact Cardiac Mapping Systems, and Non-Contact Cardiac Mapping Systems
  • Indication
    • Atrial Fibrillation, Atrial Flutter, AVNRT, And Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Biosense Webster (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Medtronic (Ireland)
  • Abbott (U.S.)
  • BIOTRONIK (Germany)
  • MicroPort Scientific Corporation (China)
  • Acutus Medical Inc. (U.S.)
  • Catheter Precision (U.S.)
  • Koninklijke Philips N.V. (Netherlands)
  • EP Solutions (Switzerland)
  • Lepu Medical Technology Co. Ltd. (China)
  • AngioDynamics (U.S.)
  • BioSig Technologies (U.S.)
  • APN Health (U.S.)
  • CoreMap (U.S.)
  • Kardium (Canada)
  • Epmap-System (Germany)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

 

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Cardiac Mapping Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Cardiac Mapping Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Cardiac Mapping Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Cardiac Mapping Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Cardiac Mapping Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Cardiac Mapping Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Cardiac Mapping Market size was valued at USD 1.86 billion in 2022 and is poised to grow from USD 2.03 billion in 2023 to USD 4.01 billion by 2031, growing at a CAGR of 8.90% during the forecast period (2024-2031).

The competitive environment of the Cardiac Mapping market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry. 'Biosense Webster (U.S.)', 'Boston Scientific Corporation (U.S.)', 'Medtronic (Ireland)', 'Abbott (U.S.)', 'BIOTRONIK (Germany)', 'MicroPort Scientific Corporation (China)', 'Acutus Medical Inc. (U.S.)', 'Catheter Precision (U.S.)', 'Koninklijke Philips N.V. (Netherlands)', 'EP Solutions (Switzerland)', 'Lepu Medical Technology Co. Ltd. (China)', 'AngioDynamics (U.S.)', 'BioSig Technologies (U.S.)', 'APN Health (U.S.)', 'CoreMap (U.S.)', 'Kardium (Canada)', 'Epmap-System (Germany)'

The anticipated growth in market revenue for cardiac mapping systems is underpinned by two key factors: the rising likelihood of an increase in cardiovascular disorders and the continuous technological advancements in cardiac mapping diagnostics. According to the World Health Organisation (WHO), cardiovascular diseases (CVDs) stand as the leading cause of mortality, responsible for approximately 17.9 million deaths annually. Notably, more than four out of every five CVD-related fatalities are attributed to heart attacks and strokes, with a significant proportion occurring in individuals under the age of 70.

During the forecast period, the cardiac imaging market is expected to witness substantial growth driven by multiple factors. Medical device companies are expected to play a key role in this trend as cutting-edge diagnostic technologies are increasingly adopted. Increasing demand for accurate cardiac testing has been identified as another major driver The growth is great because of its expansion.

The North American cardiac mapping market is poised to assert its dominance, driven by several key factors. The region's leading position is attributed to the high prevalence of Cardiovascular Diseases (CVDs), a health concern that has prompted an increasing acceptance rate of cardiac mapping systems in the United States. The validation of these systems through clinical trials further contributes to the robust demand growth anticipated over the forecast period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Cardiac Mapping Market

Report ID: SQMIG35A2783

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE